MedTech Acquisition Corporation
Status: Closed Deal
U=S+W/3
W=S@11.5
| IPO Proceeds, $M | $250.00M |
|---|---|
| IPO Date | Dec 18, 2020 |
| CEO | Christopher C. Dewey |
| Left Lead | Raymond James |
| IPO Cash in Trust | 100.0% |
| SPAC Tenor | 24 + 6 + 3 |
| IPO Sector | Healthcare ▶ |
| IPO Geography | US/Canada |
| Target Company | TriSalus Life Sciences |
| Deal Announced | Nov 14, 2022 |
| Deal Size, $M | $238.40M |
| Deal Sector | Healthcare |
| Deal Geography | US/Canada |
| SEC Filings |
www.sec.gov 
|
| Approval Vote | Aug 8, 2023 |
| Amendment Vote | Jun 12, 2023 |
| Closing Date | Aug 10, 2023 |
Formerly MTAC
TLSI
TLSIW
| Price | $4.76 |
|---|---|
| Last closing price | $4.91 |
| H/L, today | $4.71 / $4.95 |
| H/L, 52-week | $4.11 / $16.24 |
| Volume, today | 85,307 |
| Volume, 3-month avg. | N/A |
Sign up for Free Trial
No credit card required
Sign in to view structure, cap table, and calendar of events.